Bacillus Anthracis (Inhalational Anthrax) (see Anthrax)
Comments
Doxycycline is One of First-Line Agents for Inhalational Anthrax Usually in Combination with a Second Agent (Infectious Diseases Society of America, IDSA/American Thoracic Society, ATS 2007 Consensus Guidelines for the Management of CAP) (Clin Infect Dis, 2007) [MEDLINE]
Community-Acquired Pneumonia (CAP) (see Pneumonia)
Clinical Efficacy (for the Treatment of Methicillin-Resistant Staphylococcus Aureus)
There are Limited Data to Support the Use of Trimethoprim-Sulfamethoxazole, Clindamycin, Doxycycline/Minocycline in the Treatment of MRSA Community-Acquired Pneumonia (Ann Pharmacother, 2019) [MEDLINE]
Randomized Controlled trials are Required to Determine the Effectiveness of these Antibiotics in MRSA Community-Acquired Pneumonia
Clinicians Should Base Their Decision to Use These Agents on a Case-by-Case Basis Depending on Clinical Status and Susceptibility Results
XXXXXXXXX (Infectious Diseases Society of America, IDSA/American Thoracic Society, ATS 2007 Consensus Guidelines for the Management of CAP) (Clin Infect Dis, 2007) [MEDLINE]
Doxycycline is the First-Line Agent for Pneumonic Tularemia (Infectious Diseases Society of America, IDSA/American Thoracic Society, ATS 2007 Consensus Guidelines for the Management of CAP) (Clin Infect Dis, 2007) [MEDLINE]
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clin Infect Dis. 2007 Mar 1;44 Suppl 2:S27-72 [MEDLINE]
What Is the Evidence for Co-trimoxazole, Clindamycin, Doxycycline, and Minocycline in the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia?. Ann Pharmacother. 2019 Nov;53(11):1153-1161. doi: 10.1177/1060028019856721 [MEDLINE]